The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of canagliflozin compared
with sitagliptin in patients with type 2 diabetes mellitus who are receiving treatment with
metformin and sulphonylurea and have inadequate glycemic (blood sugar) control.